Markets

Watch List for Thursday 4-7-2005

RTCB, is a golf profile I did the other week, which seems to be building a base. Golf and Tennis players usually develop elbow problems which brings me to today's profile.
**********
People email me about different companies everyday, and the company I'm going to discuss here comes from the same source that notified me about CYAD and TFTG which doubled or more within 1-2 months. So could RPRV be the next big gainer? The trading on these types of companies are usually very explosive so put it on your radar.
Turn your attention to RPRV, the company is a mobile provider of extracorproeal shock wave therapy, this is a non invasive, cost effective alternative treatment to musculoskeletal pain. The RPRV wave therapy is mainly used on tennis elbow and leg pains. Get the full details on Rapid Recovery Health Services at http://www.rapidrecoveryinc.com
RPRV currently serves over 1200 physicians along the east coast, and recently announced they are moving into the Maryland area. The RPRV mobile program currently generates in excess of $250,000 in monthly revenue. RPRV uses the sonocur device to implement these treatments. The device received FDA approval in 2002. You can learn more about the device at http://www.sonorex.com/us/
After carefully reading the RPRV website, I think this company looks pretty solid. In one of their recent press releases, RPRV stated they were interested in expanding the mobile wave therapy nation wide.
Based on the current mix of insurance payers, with as little as a 10% market penetration into the existing surgical market for patients suffering from tendonapothies, there is a market for 1.25 million procedures per month. RPRV sees this figure increasing by 300% - 500% over the next 18 - 36 months as more insurance carriers begin to initiate coverage for extracorproeal wave therapy.
Company Profile:http://finance.yahoo.com/q?s=RPRV.PK
RPRV has established a mobile wave therapy Program that contracts with over 600 physicians in the NY-NJ-CT Tri-State area and is the exclusive source for low energy ESWT treatment. The mobile program is currently generating in excess of $250,000 in monthly revenue with five systems providing treatment. The Company is interested in establishing mobile routes in the top 100 market areas throughout the United States. Some of the areas include Illinois, Ohio, Wisconsin, Massachusetts, Florida, Maryland, Delaware, Texas, and California. All of which have already established reimbursement schedules for the procedure. The Company already has a fair volume of physician interest in these markets.
Market Size:
Extracorproeal wave therapy is a treatment designed to treat tendonapothies throughout the body that would otherwise require surgical treatment. Based on the demographics of our national population, wide-spread historical statistics on tendon-related ailments and coverage from insurance carriers, the Company conservatively estimates there is a market demand for over 15 million treatments per year. This figure represents approximately 10% of the existing surgical markets of patients with insurance coverage that pays for ESWT. In other words, based on the current mix of insurance payers, with as little as a 10% market penetration into the existing surgical market for patients suffering from tendonapothies, there is a market for 1.25 million procedures per month. The Company sees this figure increasing by 300% - 500% over the next 18 - 36 months as more insurance carriers begin to initiate coverage for ESWT.
Recent News
Rapid Recovery Health Services announced today that it has named four of its most trusted physician partners to its Advisory Board.PR Newswire (Mon, Apr 4)Rapid Recovery Health Services announced plans today to begin their expansion into the Maryland area PR Newswire (Wed, Mar 30)Rapid Recovery Health Services announces New Ticker Symbol; Stock Split Effective on March 2, 2005 PR Newswire (Wed, Mar 2)

posted by Juan Dosil @ 11:42 PM